HIV-1 integrase inhibitor 3
产品说明书
 |
同义名 : | - |
| CAS号 : | 1638504-56-9 | |
| 货号 : | A440163 | |
| 分子式 : | C21H22F2N4O4 | |
| 纯度 : | 98% | |
| 分子量 : | 432.42 | |
| MDL号 : | MFCD31619264 | |
| 存储条件： |
Pure form In solvent -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : | - | |
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | HIV-1 integrase inhibitor 3 is a HIV-1 integrase strand transfer (INST) inhibitor with an IC50 of 2.7 nM. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00460382 | HIV Infections | Phase 2 | Completed | - | France ... 展开 >> Hôpital Gustave Dron, Service Maladies Infectieuses Tourcoing, France, 59208 收起 << |
| NCT00887653 | HIV Hyperlipi... 展开 >>demia Hypertriglyceridemia HIV Infections 收起 << | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Tufts University Boston, Massachusetts, United States, 02111 United States, Rhode Island Miriam Hospital Immunology Clinic Providence, Rhode Island, United States, 02906 收起 << |
| NCT00887653 | - | Completed | - | - | |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.31mL 0.46mL 0.23mL |
11.56mL 2.31mL 1.16mL |
23.13mL 4.63mL 2.31mL |
